Product Code: GVR-4-68038-740-7
Non-invasive Fat Reduction Market Growth & Trends:
The global non-invasive fat reduction market size is expected to reach USD 4.3 billion by 2030, registering a CAGR of 16.2% during the forecast period, according to a new report by Grand View Research, Inc..Treatments like Cryolipolysis, low-level lasers, and Ultrasound are the most commonly used method for noninvasive fat reduction procedures. The rising contribution of market players is playing a prominent role in promoting such procedures is driving the market. Other factors like rising awareness, increasing prevalence of obesity in developed and developing countries, rise in disposable income, change in lifestyle due to urbanization, and rising demand for body contouring procedures are expected to propel the market further.
Non-invasive procedures are rapidly replacing invasive surgeries and people are opting more for aesthetic procedures like body contouring as the risk associated with these treatments are negligible and are gaining a lot of spotlight through social platforms. Behavioral Factors like physical inactivity, alcohol consumption, sedentary lifestyle, and rigorous working hours have contributed to the prevalence of conditions like obesity and diabetes. CoolScultping and Kybella were the most preferred workstations for the removal of fat in 2020.
The rise in the per capita disposable income also plays a pivotal role in the growth of this market. As stated by the U.S Bureau of Economic Analysis, disposable income reached 16661.65 USD billion as of December 2019. A combination of various factors like advancements in technology, efficacy, and safety of such procedures, increasing obese population, and rigorous promotions will certainly boost the market in the following years.
The onset of COVID-19 disrupted the aesthetic market in the first and second quarters of 2020 due to low patient footfall and the risk of virus transmission. However, the market witnessed a recovery as the procedure volume increased as the demand for aesthetic treatments escalated post-pandemic.
Non-invasive Fat Reduction Market Report Highlights:
- Cryolipolysis emerged as the largest segment in 2022 owing to increasing safety, efficacy, and negligible side effects during and after the treatment
- Based on end-use, the Hospitals segment dominated the market in 2022, as hospitals are well equipped with high-end fat reduction devices with the latest innovative technology
- North America dominated the global market in 2022. With the increasing demand for new technologies, along with advanced healthcare infrastructure, North America is expected to continue to dominate the market through the forecast perio
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Technology
- 1.1.2. End use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology Outlook
- 2.2.2. End use Outlook
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Non-invasive Fat Reduction Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Non-invasive Fat Reduction Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.3. Major Deals & Strategic Alliances Analysis
- 3.4.4. Market Entry Strategies
Chapter 4. Non-invasive Fat Reduction Market: Technology Estimates & Trend Analysis
- 4.1. Non-invasive Fat Reduction Market, By Technology Key Takeaways
- 4.2. Non-invasive Fat Reduction Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Cryolipolysis
- 4.3.1. Cryolipolysis market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Lower-level Lasers
- 4.4.1. Lower-level laser market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Ultra-sound
- 4.5.1. Ultra-sound market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Non-invasive Fat Reduction Market: End-use Estimates & Trend Analysis
- 5.1. Non-invasive Fat Reduction Market, By End-use Key Takeaways
- 5.2. Non-invasive Fat Reduction Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Hospitals
- 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Standalone Practices
- 5.4.1. Stand-alone practices market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Multispecialty Clinics
- 5.5.1. Multispecialty clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.2. Others
- 5.5.3. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Non-invasive Fat Reduction Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Non-invasive Fat Reduction Market: by Region: Key Takeaways
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Cynosure, Inc.
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Fosun Pharmaceuticals Co. Ltd.
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Lynton Laser Ltd.
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Cutera, Inc.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. ZELTIQ Aesthetics, Inc.
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Syneron Medical
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. BTL
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Venus Concept
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Candela Corporation
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Hologic, Inc.
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. AbbVie, Inc.
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives